These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32527346)

  • 1. [Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease 2019].
    Wen L; Zhou Z; Jiang D; Huang K
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):426-429. PubMed ID: 32527346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
    Chen L; Zhang A; Li Q; Cui Y; Yuan G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Xuebijing on inflammatory response and prognosis in patients with septic shock].
    Sun R; Liang M; Yang H; Liu Q; Ma N; Wei D; Dong F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):458-462. PubMed ID: 32527353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xuebijing injection in the treatment of COVID-19: a retrospective case-control study.
    Guo H; Zheng J; Huang G; Xiang Y; Lang C; Li B; Huang D; Sun Q; Luo Y; Zhang Y; Huang L; Fang W; Zheng Y; Wan S
    Ann Palliat Med; 2020 Sep; 9(5):3235-3248. PubMed ID: 32954754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Xuebijing injection on postoperative inflammatory response in patients after hepatobiliary and pancreatic surgeries: a retrospective cohort study].
    Xie H; Wang K; Liang X; Sun H; Zhou J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Oct; 30(10):983-986. PubMed ID: 30439322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019].
    Liu X; Song Y; Guan W; Qiu H; Du B; Li Y; Liu Y; Shang H; Zhong N; Coronavirus Disease Emergency Project Research Collaboration G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):774-778. PubMed ID: 34412743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The protective effect of Xuebijing injection pretreatment on hepatic ischemia reperfusion injury and coagulopathy after excision of liver cancer].
    Shen J; Lin XJ; Cui BK; Chi PD; Zeng QY; Zhao QY
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Dec; 25(12):743-8. PubMed ID: 24620386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
    Xu J; Zhao F; Han M; Ma L; Zhang T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):401-406. PubMed ID: 32527341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The DNA binding activity of nuclear factor-ΚB in patients with severe pneumonia and the intervention effects of Xuebijing injection].
    Gong BL; Zhang Y; Xu QX; Chen YQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Sep; 22(9):543-6. PubMed ID: 20854735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Xuebijing injection on hemodynamics and endothelial function in patients with severe sepsis: a prospective study].
    He J; Tan Z; Zhang M; Guo L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):127-32. PubMed ID: 25665612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratory characteristics of 215 cases of coronavirus disease 2019 with different prognosis].
    Zhu M; Zhu Y; Guo F; Zhang J; Liu W; Hou W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1428-1433. PubMed ID: 33541492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
    Fei M; Tong F; Tao X; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and CT imaging features of patients with different clinical types of coronavirus disease 2019].
    Liu C; Deng X; Pan Y; Ling Z; Zhang G; Wei G; Peng P; He X; Zhang F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):548-553. PubMed ID: 32576345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy and safety of Xuebijing injection on sepsis: a Meta-analysis].
    Wu Y; Zhang J; Qi L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):691-695. PubMed ID: 32684214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A prospective randomized control clinical study of the effect of Xuebijing injection on prognosis of acute respiratory distress syndrome patients].
    Chen QH; Zheng RQ; Lin H; Wang HL; Lu NF; Shao J; Yu JQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jul; 21(7):405-8. PubMed ID: 19615131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
    Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
    Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].
    Zhang J; Li J; Su L; Yang J; Jiang X; Jiang N; Lei Y; He L; Lu Q; Shen S; Chen F; Peng Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):407-411. PubMed ID: 32527342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy and safety of different antiviral regimens in patients with coronavirus disease 2019].
    Gao X; Ma C; Ma Y; Wang X; Wei J; Feng T; Zhao G; Xu L; Zhou W; Zheng X; Zhao Q; Cao X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1423-1427. PubMed ID: 33541491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.